• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为造血细胞移植的长期成年幸存者提供护理。

Delivering care to long-term adult survivors of hematopoietic cell transplantation.

机构信息

Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.

出版信息

J Clin Oncol. 2012 Oct 20;30(30):3746-51. doi: 10.1200/JCO.2012.42.3038. Epub 2012 Sep 24.

DOI:10.1200/JCO.2012.42.3038
PMID:23008296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3675679/
Abstract

This review highlights long-term and late consequences of hematopoietic cell transplantation (HCT) as well as strategies to manage or prevent complications that are more prevalent after HCT than most other cancer treatments. Chronic graft-versus-host disease stands out as a unique late effect of allogeneic HCT that is not seen after other types of cancer treatment. However, many other complications seen after solid tumor treatments are also common after HCT, including infections, second cancers, bone loss, and cardiovascular, pulmonary, renal, and endocrine dysfunction. Symptoms and syndromes that are reported after HCT include sexual dysfunction, cognitive problems, fatigue, insomnia, musculoskeletal symptoms, emotional distress, anger, and depression. Addressing these complex potential or actual complications requires diligent routine health care to intervene early or, when possible, to prevent late complications. To accomplish early detection and prevention of life-threatening complications, HCT survivors should undergo an annual comprehensive physical examination that includes screening for functional and psychosocial consequences of treatment and encouraging healthy lifestyle behaviors. Clinicians can link survivors to numerous online, print, and video resources to help them advocate for their health needs.

摘要

这篇综述重点介绍了造血细胞移植(HCT)的长期和晚期后果,以及管理或预防并发症的策略,这些并发症在 HCT 后比大多数其他癌症治疗更为常见。慢性移植物抗宿主病是同种异体 HCT 的一种独特的晚期效应,在其他类型的癌症治疗后不会出现。然而,许多在实体瘤治疗后出现的其他并发症在 HCT 后也很常见,包括感染、第二癌症、骨质流失以及心血管、肺、肾和内分泌功能障碍。HCT 后报告的症状和综合征包括性功能障碍、认知问题、疲劳、失眠、肌肉骨骼症状、情绪困扰、愤怒和抑郁。解决这些复杂的潜在或实际并发症需要进行勤奋的常规保健,以便早期干预或在可能的情况下预防晚期并发症。为了实现对危及生命的并发症的早期检测和预防,HCT 幸存者应每年进行全面体检,包括筛查治疗的功能和社会心理后果,并鼓励健康的生活方式行为。临床医生可以将幸存者与众多在线、印刷和视频资源联系起来,以帮助他们倡导自己的健康需求。

相似文献

1
Delivering care to long-term adult survivors of hematopoietic cell transplantation.为造血细胞移植的长期成年幸存者提供护理。
J Clin Oncol. 2012 Oct 20;30(30):3746-51. doi: 10.1200/JCO.2012.42.3038. Epub 2012 Sep 24.
2
Surviving the cure: long term followup of hematopoietic cell transplant recipients.治愈后的生存:造血细胞移植受者的长期随访。
Bone Marrow Transplant. 2013 Sep;48(9):1145-51. doi: 10.1038/bmt.2012.258. Epub 2013 Jan 7.
3
The management of gynecological complications in long-term survivors after allogeneic hematopoietic cell transplantation-a single-center real-life experience.异基因造血细胞移植后长期生存者妇科并发症的管理:单中心真实经验。
Ann Hematol. 2020 Jun;99(6):1361-1368. doi: 10.1007/s00277-020-04034-1. Epub 2020 Apr 28.
4
The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls.癌症和造血干细胞移植长期幸存者与匹配对照者的预防保健行为比较。
Biol Blood Marrow Transplant. 2010 Feb;16(2):207-14. doi: 10.1016/j.bbmt.2009.09.015. Epub 2009 Sep 23.
5
Long-term Follow-up of Hematopoietic Stem Cell Transplant Survivors: A Focus on Screening, Monitoring, and Therapeutics.造血干细胞移植存活者的长期随访:重点关注筛查、监测和治疗。
Pharmacotherapy. 2020 Aug;40(8):808-841. doi: 10.1002/phar.2443.
6
Long term survival among patients who are disease free at 1-year post allogeneic hematopoietic cell transplantation: a single center analysis of 389 consecutive patients.异基因造血细胞移植后1年无病患者的长期生存:389例连续患者的单中心分析
Bone Marrow Transplant. 2018 May;53(5):576-583. doi: 10.1038/s41409-017-0076-2. Epub 2018 Jan 15.
7
Late Mortality and Causes of Death among Long-Term Survivors after Allogeneic Stem Cell Transplantation.异基因造血干细胞移植后长期存活者的晚期死亡率及死亡原因
Biol Blood Marrow Transplant. 2016 Sep;22(9):1702-1709. doi: 10.1016/j.bbmt.2016.05.019. Epub 2016 May 28.
8
Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation.造血细胞移植后幸存者的非恶性晚期效应和功能状态受损。
J Clin Oncol. 2012 Jan 1;30(1):71-7. doi: 10.1200/JCO.2011.38.4594. Epub 2011 Dec 5.
9
Impact of cGVHD on socioeconomic outcomes in survivors with pediatric hematopoietic stem cell transplant in Japan: a cross-sectional observational study.日本儿童造血干细胞移植存活者中慢性移植物抗宿主病对社会经济结局的影响:一项横断面观察性研究。
Int J Hematol. 2021 Apr;113(4):566-575. doi: 10.1007/s12185-020-03058-7. Epub 2021 Jan 2.
10
Caring for the long-term survivor after allogeneic stem cell transplantation.异基因造血干细胞移植后长期存活者的护理
Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):495-503. doi: 10.1182/asheducation-2014.1.495. Epub 2014 Nov 18.

引用本文的文献

1
Genital Graft-Versus-Host-Disease Predicts Decreased Sexual Function in Female Survivors of Allogeneic Hematopoietic Stem Cell Transplant.生殖器移植物抗宿主病预示着异基因造血干细胞移植女性幸存者性功能下降。
Transplant Cell Ther. 2025 Jun 18. doi: 10.1016/j.jtct.2025.06.021.
2
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part III. Long-Term Impact of Chronic Graft-versus-Host Disease on Endocrinologic, Cardiovascular, and Metabolic Outcomes in Survivors of Pediatric Hematopoietic Cell Transplantation.儿科移植与细胞治疗联盟造血细胞移植后小儿慢性移植物抗宿主病幸存者的RESILIENT会议:第三部分。慢性移植物抗宿主病对小儿造血细胞移植幸存者内分泌、心血管和代谢结局的长期影响。
Transplant Cell Ther. 2025 May;31(5):297.e1-297.e15. doi: 10.1016/j.jtct.2025.01.891. Epub 2025 Feb 12.
3
Prehabilitation to improve function after autologous stem cell transplantation: A pilot randomized controlled trial (PIRATE).自体干细胞移植后进行预康复以改善功能:一项试点随机对照试验(PIRATE)。
Support Care Cancer. 2025 Feb 7;33(3):164. doi: 10.1007/s00520-025-09179-1.
4
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part II. Organ Dysfunction and Immune Reconstitution Considerations for Children with Chronic Graft-versus-Host Disease after Hematopoietic Cell Transplantation.儿科移植与细胞治疗联盟造血细胞移植后小儿慢性移植物抗宿主病生存的RESILIENT会议:第二部分。造血细胞移植后慢性移植物抗宿主病患儿的器官功能障碍与免疫重建考量
Transplant Cell Ther. 2025 Jan 22. doi: 10.1016/j.jtct.2025.01.885.
5
Prehabilitation to improve outcomes afteR Autologous sTem cEll transplantation (PIRATE): A pilot randomised controlled trial protocol.自体干细胞移植后康复治疗改善预后(PIRATE):一项先导随机对照试验方案。
PLoS One. 2023 Apr 27;18(4):e0277760. doi: 10.1371/journal.pone.0277760. eCollection 2023.
6
Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe.欧洲脐带血移植后继发肿瘤的结果。
Blood Adv. 2023 May 23;7(10):1976-1986. doi: 10.1182/bloodadvances.2022007941.
7
A person-centred intervention remotely targeting family caregivers' support needs in the context of allogeneic hematopoietic stem cell transplantation-a feasibility study.以患者为中心的干预措施,针对异基因造血干细胞移植背景下的家庭照顾者的支持需求,一种可行性研究。
Support Care Cancer. 2022 Nov;30(11):9039-9047. doi: 10.1007/s00520-022-07306-w. Epub 2022 Aug 11.
8
A biobehavioral intervention to enhance recovery following hematopoietic cell transplantation: Protocol for a feasibility and acceptability randomized control trial.一种促进造血细胞移植后恢复的生物行为干预措施:一项可行性和可接受性随机对照试验方案
Contemp Clin Trials Commun. 2022 May 28;28:100938. doi: 10.1016/j.conctc.2022.100938. eCollection 2022 Aug.
9
Mediating effect of ill perception on the relationship between social constraints and fear of cancer recurrence among adolescent and young adult survivors who underwent hematopoietic stem cell transplantation.疾病认知在接受造血干细胞移植的青少年和青年幸存者的社会限制与癌症复发恐惧之间关系中的中介作用。
Asia Pac J Oncol Nurs. 2022 Apr 7;9(5):100060. doi: 10.1016/j.apjon.2022.03.012. eCollection 2022 May.
10
Long-term patient-reported neurocognitive outcomes in adult survivors of hematopoietic cell transplant.造血细胞移植后成年幸存者的长期患者报告神经认知结局。
Blood Adv. 2022 Jul 26;6(14):4347-4356. doi: 10.1182/bloodadvances.2021006672.

本文引用的文献

1
Community-based exercise program effectiveness and safety for cancer survivors.基于社区的锻炼计划对癌症幸存者的有效性和安全性。
J Cancer Surviv. 2012 Jun;6(2):219-28. doi: 10.1007/s11764-011-0213-7. Epub 2012 Jan 13.
2
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.造血细胞移植后长期生存者的推荐筛查和预防措施。
Biol Blood Marrow Transplant. 2012 Mar;18(3):348-71. doi: 10.1016/j.bbmt.2011.12.519. Epub 2011 Dec 13.
3
Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation.造血细胞移植后幸存者的非恶性晚期效应和功能状态受损。
J Clin Oncol. 2012 Jan 1;30(1):71-7. doi: 10.1200/JCO.2011.38.4594. Epub 2011 Dec 5.
4
The impact of hematopoietic stem cell transplantation on sexuality: a systematic review of the literature.造血干细胞移植对性行为的影响:文献系统评价。
Bone Marrow Transplant. 2012 May;47(5):716-24. doi: 10.1038/bmt.2011.169. Epub 2011 Aug 29.
5
Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS).造血细胞移植后长期生存者的不良心理结局:来自骨髓移植生存者研究(BMTSS)的报告。
Blood. 2011 Oct 27;118(17):4723-31. doi: 10.1182/blood-2011-04-348730. Epub 2011 Aug 5.
6
Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation.造血干细胞移植受者的心血管住院治疗和死亡率。
Ann Intern Med. 2011 Jul 5;155(1):21-32. doi: 10.7326/0003-4819-155-1-201107050-00004.
7
2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders.国际血液和骨髓移植研究中心(CIBMTR)2010年报告:造血细胞移植在血液和骨髓疾病中的当前应用及结果
Clin Transpl. 2010:87-105.
8
Development and implementation of an Internet-based survivorship care program for cancer survivors treated with hematopoietic stem cell transplantation.基于互联网的造血干细胞移植治疗癌症幸存者生存护理计划的制定与实施。
J Cancer Surviv. 2011 Sep;5(3):292-304. doi: 10.1007/s11764-011-0182-x. Epub 2011 May 5.
9
Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years.癌症幸存者接受异基因造血细胞移植后 5 年的前瞻性神经认知功能与 5 年时匹配对照者的比较。
J Clin Oncol. 2011 Jun 10;29(17):2397-404. doi: 10.1200/JCO.2010.33.9119. Epub 2011 May 2.
10
Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.异基因造血细胞移植后的长期生存和晚期死亡。
J Clin Oncol. 2011 Jun 1;29(16):2230-9. doi: 10.1200/JCO.2010.33.7212. Epub 2011 Apr 4.